Patents by Inventor Keith Edward Thornton

Keith Edward Thornton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10752962
    Abstract: Methods and compositions for detection of Neisseria gonorrhoeae are disclosed herein. In some embodiments, the presence or absence of N. gonorrhoeae in a sample is determined using nucleic acid-based testing methods using primers and/or probes that bind to opcA gene region of N. gonorrhoeae.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: August 25, 2020
    Assignee: Becton, Dickinson and Company
    Inventors: Keith Edward Thornton, Paul Madepogu, Danielle Koffenberger
  • Patent number: 10308984
    Abstract: Nucleic acids sequences that can be used for nucleic acid amplification, for example quantitative nucleic acid amplification, are provided herein.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: June 4, 2019
    Assignee: BECTON, DICKINSON AND COMPANY
    Inventors: Keith Edward Thornton, Danielle Koffenberger, Paul Madepogu
  • Publication number: 20190002961
    Abstract: Methods and compositions for detection of Neisseria gonorrhoeae are disclosed herein. In some embodiments, the presence or absence of N. gonorrhoeae in a sample is determined using nucleic acid-based testing methods using primers and/or probes that bind to opcA gene region of N. gonorrhoeae.
    Type: Application
    Filed: June 6, 2018
    Publication date: January 3, 2019
    Inventors: Keith Edward Thornton, Paul Madepogu, Danielle Koffenberger
  • Patent number: 9994916
    Abstract: Methods and compositions for detection of Neisseria gonorrhoeae are disclosed herein. In some embodiments, the presence or absence of N. gonorrhoeae in a sample is determined using nucleic acid-based testing methods using primers and/or probes that bind to opcA gene region of N. gonorrhoeae.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: June 12, 2018
    Assignee: Becton, Dickinson and Company
    Inventors: Keith Edward Thornton, Paul Madepogu, Danielle Koffenberger
  • Publication number: 20180112262
    Abstract: Nucleic acids sequences that can be used for nucleic acid amplification, for example quantitative nucleic acid amplification, are provided herein.
    Type: Application
    Filed: October 11, 2017
    Publication date: April 26, 2018
    Inventors: Keith Edward Thornton, Danielle Koffenberger, Paul Madepogu
  • Patent number: 9499858
    Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: November 22, 2016
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, Tobin Hellyer, Dolores M. Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha-Sha Wang, Keith Edward Thornton
  • Publication number: 20160024560
    Abstract: Methods and compositions for detection of Neisseria gonorrhoeae are disclosed herein. In some embodiments, the presence or absence of N. gonorrhoeae in a sample is determined using nucleic acid-based testing methods using primers and/or probes that bind to opcA gene region of N. gonorrhoeae.
    Type: Application
    Filed: March 7, 2014
    Publication date: January 28, 2016
    Inventors: Keith Edward Thornton, Paul Madepogu, Danielle Koffenberger
  • Publication number: 20150152473
    Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.
    Type: Application
    Filed: January 11, 2013
    Publication date: June 4, 2015
    Applicant: BECTON, DICKINSON AND COMPANY
    Inventors: James G. Nadeau, Tobin Hellyer, Dolores M. Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha-Sha Wang, Keith Edward Thornton
  • Publication number: 20150050651
    Abstract: Nucleic acids sequences that can be used for nucleic acid amplification, for example quantitative nucleic acid amplification, are provided herein.
    Type: Application
    Filed: March 13, 2013
    Publication date: February 19, 2015
    Applicant: Becton, Dickinson and Company
    Inventors: Keith Edward Thornton, Danielle Koffenberger, Paul Madepogu
  • Patent number: 8372605
    Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: February 12, 2013
    Assignee: Becton, Dickinson and Company
    Inventors: James Nadeau, Tobin J. Hellyer, Dolores M. Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha-Sha Wang, Keith Edward Thornton